GlassScriptPhysician profile
Barry M Spiegel
NPI 1912909193
$3,509.44
in general payments reported to CMS, 2019-2025
38 companies · $21.22 in 2025
The $21.22 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,211 · 2022: $1,085 · 2023: $1,070 · 2024: $122 · 2025: $21.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,213.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $755.29 | 2021-2024 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $415.37 | 2021-2023 | |
| Lilly USA, LLC | $216.06 | 2021-2024 | Mounjaro, Jardiance, Zepbound |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $167.88 | 2022-2023 | |
| Glaxosmithkline, LLC. | $154.18 | 2021-2024 | Shingrix, Arexvy |
| Merck Sharp & Dohme LLC | $152.16 | 2021-2023 | Verquvo, Steglatro, Belsomra |
| Astrazeneca Pharmaceuticals LP | $149.57 | 2021-2024 | Airsupra, Farxiga |
| Abbott Laboratories | $119.73 | 2022-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $117.15 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $114.07 | 2021-2023 | |
| Pfizer INC. | $91.08 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.49 | 2021-2023 | Synjardy, Jardiance |
| Grifols USA, LLC | $77.95 | 2021-2023 | Prolastin-C Liquid |
| Esperion Therapeutics, INC. | $76.23 | 2021 | |
| Novartis Pharmaceuticals Corporation | $70.76 | 2022-2023 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Spiegel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.